Skip to main content
Clinical Trials/NCT03281460
NCT03281460CompletedNot Applicable

Efficacy of In-bag Morcellation

Hospices Civils de Lyon2 sites in 1 country48 target enrollmentStarted: January 25, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
48
Locations
2
Primary Endpoint
Smooth muscular cells in the peritoneal fluid after morcellation

Study Overview

Brief Summary

Laparoscopic mini-invasive surgery supplanted laparotomy for many years, including hysterectomy or myomectomy (less postoperative complications compared to laparotomy) However the US Federal Drug Administration (FDA) strongly warned against the use of power morcellation in 2014 because of the risk of iatrogenic spread of malignant cells.

The hypothesis is that in-bag morcellation may prevent cells dissemination. The investigator compare in this prospective randomized study two groups of patients: group A (in bag-morcellation during laparoscopic myomectomy or hysterectomy) versus group B (morcellation without any bag during laparoscopic myomectomy or hysterectomy)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women aged 18 years or more
  • Laparoscopic myomectomy or laparoscopic subtotal hysterectomy
  • Informed and signed consent

Exclusion Criteria

  • Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
  • Preoperative risk of leiomyosarcoma or pelvic carcinoma
  • Pregnancy or desire of pregnancy during the study period
  • Uterus or myomas weight above 1.000 g
  • Inability to understand information provided
  • Not covered by a national health insurance scheme, prisoner or under administrative supervision

Arms & Interventions

with in-bag morcellation

Experimental

with More-cell-Safe AMI bag morcellation

Intervention: laparoscopic myomectomy or hysterectomy with More-cell-Safe AMI bag morcellation (Device)

without any morcellation bag

Active Comparator

without any morcellation bag

Intervention: laparoscopic myomectomy or hysterectomy without any morcellation bag (Procedure)

Outcomes

Primary Outcomes

Smooth muscular cells in the peritoneal fluid after morcellation

Time Frame: Day 0 - just after surgery

After morcellation, there will be cytology and immunohistochemistry of peritoneal washing with 500cc of saline serum

Secondary Outcomes

  • duration of surgery(Day 0)
  • morcellation time(Day 0 - during surgery)
  • peritoneal washing time(Day 0 - during surgery)
  • residual morcellated tissues weight(Day 0 - during surgery)
  • bag associated time(Day 0 - during surgery)
  • ease of use(Day 0 - during surgery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Efficacy of In-bag Morcellation | Clinical Trial